Summary: A new study reveals a direct link between altered brain activity and social deficits in ASD.
Source: CHOP.
One in 59 children are diagnosed with an Autism Spectrum Disorder (ASD), a wide array of conditions affecting a child’s social, emotional, and behavioral development. With prevalence growing at an unprecedented rate – it has nearly tripled in the last 15 years – scientists race to understand ASD. While genetic and environmental influences have been implicated as potential causes of ASD, little is known about its neurobiology.
Now, researchers at Children’s Hospital Los Angeles have brought us one step closer.
In a study published January 30th in the journal Biological Psychiatry, CHLA’s Bradley Peterson, MD, uncovers a direct link between altered brain activity and social deficits in ASD. Peterson’s group studied 44 individuals with ASD and compared them with 66 typically-developing participants. Groups were matched for age, sex, and IQ.
Peterson’s team used advanced imaging techniques to acquire two types of information. First, the group used a method called arterial spin labeling, which measures blood flow through the vessels of the brain. Because active parts of the brain need the most oxygen and nutrients, more blood flow to an area signals increased brain activity. Second, the team measured levels of NAA, an amino acid byproduct commonly used as a marker of healthy neurons.
“This is a multimodal imaging data set,” explains Peterson, Director of the Institute for the Developing Mind at CHLA and Professor of Pediatrics at the Keck School of Medicine of USC. “Each modality gives us a different window into the brain. We are able to look through both windows at once to tell us much more about what’s going on in the brains of these individuals.”
Scans revealed a striking pattern in the part of the brain called the white matter.
Our brains have about 100 billion cells, which communicate with each other through long, wire-like branches called axons. These axons are coated with myelin, a specialized wrapping – like wire insulation – that helps the messages flow faster from one cell to another. Because myelin appears white, communication pathways between cells are collectively called white matter. Cell bodies, or gray matter, are not coated as extensively in myelin and therefore do not appear white.
Studies show that communication between distant brain cells is disrupted in ASD due to fewer long-range connections between cells and thinner myelin. Given these differences in white matter, decreased blood flow and activity in this region would make sense.
Yet, Peterson and his team found exactly the opposite.
In the study, the researchers found what is called hyperperfusion – increased blood flow, indicating more brain activity – throughout large portions of white matter in participants with ASD. Perhaps even more striking, these activity rates were correlated with ADOS scores; ADOS is a tool used by doctors to help diagnose ASD.
If white matter is compromised in ASD, one might expect decreased activity in this region, not increased. Peterson explains that this finding likely reveals an attempt to compensate for underlying white matter problems. “If the drive train in your car is compromised, you have to hit the gas harder to achieve the same speed,” he explains. Similarly, supporting cells in the brain that create and maintain the myelin wrapping seem to be working overtime to counteract deficits in the underlying axon. This compensatory mechanism may partially explain why many individuals with ASD are high functioning. “This correlation of perfusion and ADOS is absolutely key,” emphasizes Peterson, “because it shows that the higher the blood flow, the more ASD symptoms the participants have. This very solidly supports the idea of compensation.”
Looking in the second window – measuring NAA concentrations as a marker for healthy neurons – revealed support for this idea of compensation. “We found that in participants with autism, the lower the NAA concentrations were, the higher their perfusion was at those points in the brain,” Peterson says. In other words, areas with the lowest levels of healthy neurons were also the ones with the highest activity and blood flow.
The majority of autism research has focused on other parts of neurons, as opposed to axons. Peterson’s study marks the first to correlate widespread white matter hyperperfusion, healthy neuron biomarkers, and symptom scores. The study paves the way for understanding more about how the brain may compensate for compromised white matter signaling. “Axons and their supporting cells have not been a major focus in autism research,” Peterson says. “My hope is that this study will help to refocus attention on the cell types and brain areas that are critical in understanding the neurological basis for ASD.”
Additional authors on the study include Ariana Zargarian, Jarod B. Peterson, Suzanne Goh, Siddhant Sawardekar, Steven C. R. Williams, David J. Lythgoe, Fernando O. Zelaya, and Ravi Bansal.
Funding: This study was supported by National Institute of Mental Health grant R01 MH089582 and funding from Children’s Hospital Los Angeles and the University of Southern California.
Source: Melinda Smith – CHOP
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is credited to CHOP.
Original Research: Abstract for “Hyperperfusion of Frontal White and Subcortical Gray Matter in Autism Spectrum Disorder” by Bradley S. Peterson, Ariana Zargarian, Jarod B. Peterson, Suzanne Goh, Siddhant Sawardekar, Steven C.R. Williams, David J. Lythgoe, Fernando O. Zelaya, and Ravi Bansal in Biological Psychiatry. Published January 25 2019.
doi:10.1016/j.biopsych.2018.11.026
[cbtabs][cbtab title=”MLA”]CHOP”Two Windows Into the Brain.” NeuroscienceNews. NeuroscienceNews, 30 January 2019.
<https://neurosciencenews.com/asd-brain-activity-10662/>.[/cbtab][cbtab title=”APA”]CHOP(2019, January 30). Two Windows Into the Brain. NeuroscienceNews. Retrieved January 30, 2019 from https://neurosciencenews.com/asd-brain-activity-10662/[/cbtab][cbtab title=”Chicago”]CHOP”Two Windows Into the Brain.” https://neurosciencenews.com/asd-brain-activity-10662/ (accessed January 30, 2019).[/cbtab][/cbtabs]
Abstract
Hyperperfusion of Frontal White and Subcortical Gray Matter in Autism Spectrum Disorder
Background
Our aim was to assess resting cerebral blood flow (rCBF) in children and adults with autism spectrum disorder (ASD).
Methods
We acquired pulsed arterial spin labeling magnetic resonance imaging data in 44 generally high-functioning participants with ASD simplex and 66 typically developing control subjects with comparable mean full-scale IQs. We compared rCBF values voxelwise across diagnostic groups and assessed correlations with symptom scores. We also assessed the moderating influences of participant age, sex, and IQ on our findings and the correlations of rCBF with N-acetylaspartate metabolite levels.
Results
We detected significantly higher rCBF values throughout frontal white matter and subcortical gray matter in participants with ASD. rCBF correlated positively with socialization deficits in participants with ASD in regions where hyperperfusion was greatest. rCBF declined with increasing IQ in the typically developing group, a correlation that was absent in participants with ASD, whose rCBF values were elevated across all IQ levels. rCBF in the ASD group correlated inversely with N-acetylaspartate metabolite levels throughout the frontal white matter, with greater rCBF accompanying lower and increasingly abnormal N-acetylaspartate levels relative to those of typically developing control subjects.
Conclusions
These findings taken together suggest the presence of altered metabolism, likely of mitochondrial origin, and dysfunctional maintenance processes that support axonal functioning in ASD. These disturbances in turn likely reduce neural efficiency for cognitive and social functioning and trigger compensatory responses from supporting glial cells, which subsequently increase rCBF to affected white matter. These findings, if confirmed, suggest cellular and molecular targets for novel therapeutics that address axonal pathology and bolster glial compensatory responses in ASD.
